OMQS 10-Q Quarterly Report March 31, 2025 | Alphaminr

OMQS 10-Q Quarter ended March 31, 2025

OMNIQ CORP.
10-Ks and 10-Qs
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
false --12-31 Q1 0000278165 0000278165 2025-01-01 2025-03-31 0000278165 2025-05-12 0000278165 2025-03-31 0000278165 2024-12-31 0000278165 us-gaap:SeriesAPreferredStockMember 2025-03-31 0000278165 us-gaap:SeriesAPreferredStockMember 2024-12-31 0000278165 us-gaap:SeriesBPreferredStockMember 2025-03-31 0000278165 us-gaap:SeriesBPreferredStockMember 2024-12-31 0000278165 us-gaap:SeriesCPreferredStockMember 2025-03-31 0000278165 us-gaap:SeriesCPreferredStockMember 2024-12-31 0000278165 2024-01-01 2024-03-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-12-31 0000278165 us-gaap:CommonStockMember 2023-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000278165 us-gaap:RetainedEarningsMember 2023-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000278165 2023-12-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-12-31 0000278165 us-gaap:CommonStockMember 2024-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000278165 us-gaap:RetainedEarningsMember 2024-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-01-01 2024-03-31 0000278165 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000278165 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-03-31 0000278165 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000278165 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-03-31 0000278165 us-gaap:CommonStockMember 2024-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000278165 us-gaap:RetainedEarningsMember 2024-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000278165 2024-03-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2025-03-31 0000278165 us-gaap:CommonStockMember 2025-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000278165 us-gaap:RetainedEarningsMember 2025-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000278165 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0000278165 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0000278165 us-gaap:WarrantMember 2025-01-01 2025-03-31 0000278165 us-gaap:WarrantMember 2024-01-01 2024-03-31 0000278165 OMQS:BlueStarMember 2025-03-31 0000278165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OMQS:NoCustomerMember 2025-01-01 2025-03-31 0000278165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OMQS:OneCustomerMember 2024-01-01 2024-12-31 0000278165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember OMQS:OneCustomerMember 2025-01-01 2025-03-31 0000278165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember OMQS:OneCustomerMember 2024-01-01 2024-12-31 0000278165 us-gaap:CostOfGoodsSegmentMember us-gaap:CustomerConcentrationRiskMember OMQS:OneVendorMember 2025-01-01 2025-03-31 0000278165 us-gaap:CostOfGoodsSegmentMember us-gaap:CustomerConcentrationRiskMember OMQS:OneVendorMember 2024-01-01 2024-12-31 0000278165 OMQS:SharePurchaseAgreementMember OMQS:CodeBlocksLtdMember 2024-01-30 2024-01-30 0000278165 OMQS:SharePurchaseAgreementMember OMQS:CodeBlocksLtdMember 2024-01-30 0000278165 OMQS:SharePurchaseAgreementMember OMQS:CodeBlocksLtdMember 2025-03-31 0000278165 OMQS:PurchaseAndSaleAgreementMember 2024-01-18 0000278165 OMQS:PurchaseAndSaleAgreementMember 2025-03-31 0000278165 OMQS:NotePayableMarinMember us-gaap:RelatedPartyMember 2017-12-31 0000278165 OMQS:NotePayableMarinMember us-gaap:RelatedPartyMember 2017-12-01 2017-12-31 0000278165 OMQS:NotePayableMarinMember us-gaap:RelatedPartyMember 2025-03-31 0000278165 OMQS:NotePayableMarinMember us-gaap:RelatedPartyMember 2024-12-31 0000278165 OMQS:LeumiBankMember 2021-07-29 0000278165 OMQS:LeumiBankMember 2021-07-28 2021-07-29 0000278165 OMQS:LeumiBankMember 2024-12-31 0000278165 OMQS:LeumiBankMember 2025-03-31 0000278165 2021-08-11 0000278165 2021-08-10 2021-08-11 0000278165 OMQS:HapoalimBankMember 2022-09-13 0000278165 OMQS:HapoalimBankMember 2022-09-13 2022-09-13 0000278165 OMQS:HapoalimBankMember 2025-03-31 0000278165 OMQS:HapoalimBankMember 2023-12-31 0000278165 OMQS:HapoalimBankMember 2023-01-01 2023-12-31 0000278165 OMQS:HapoalimBankMember 2024-12-31 0000278165 OMQS:HapoalimBankMember 2024-02-29 0000278165 OMQS:HapoalimBankMember 2024-02-01 2024-02-29 0000278165 OMQS:HapoalimBankMember us-gaap:LongTermDebtMember 2024-07-31 0000278165 OMQS:HapoalimBankMember us-gaap:LongTermDebtMember 2024-07-01 2024-07-31 0000278165 OMQS:LeumiBankMember 2023-12-31 0000278165 OMQS:LeumiBankMember 2023-01-01 2023-12-31 0000278165 OMQS:LeumiBankMember us-gaap:LongTermDebtMember 2024-03-31 0000278165 OMQS:LeumiBankMember us-gaap:LongTermDebtMember 2024-03-01 2024-03-31 0000278165 OMQS:LeumiBankMember us-gaap:LongTermDebtMember 2024-12-31 0000278165 OMQS:TzameretMember 2023-09-21 0000278165 OMQS:TzameretMember 2023-09-21 2023-09-21 0000278165 OMQS:TzameretMember 2024-12-31 0000278165 OMQS:TzameretMember 2025-03-31 0000278165 us-gaap:SeriesAPreferredStockMember 2025-01-01 2025-03-31 0000278165 us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-03-31 0000278165 OMQS:EquityIncentivePlanMember 2021-10-31 0000278165 OMQS:EquityIncentivePlanMember 2025-01-01 2025-03-31 0000278165 OMQS:EquityIncentivePlanMember 2024-01-01 2024-03-31 0000278165 2024-11-03 2024-11-03 0000278165 2025-03-01 2025-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares OMQS:Integer iso4217:ILS xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: March 31, 2025

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from________ to__________

Commission File Number: 001-40768

OMNIQ Corp.

(Exact name of registrant as specified in its charter)

Delaware 20-3454263

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer

Identification No.)

1865 West 2100 South

Salt Lake City , UT 84119

(Address of principal executive offices) (Zip Code)

(801) 242-7272

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Ticker symbol(s) Name of each exchange on which registered
Common Stock, $0.001 par value OMQS OTCMKTS

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
(Do not check if a smaller reporting company)
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 10,702,930 shares of common stock, $ 0.001 par value, as of May 12, 2025.

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION F-1
ITEM 1. FINANCIAL STATEMENTS F-1
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS AT MARCH 31, 2025 AND DECEMBER 31, 2024 F-1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS FOR THE THREE MONTHS ENDED MARCH 31, 2025, AND 2024 F-2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) FOR THE THREE MONTHS ENDED MARCH 31, 2025 AND 2024 F-3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE THREE MONTHS ENDED MARCH 31, 2025, AND 2024 F-4
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS F-5
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 3
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 6
ITEM 4. CONTROLS AND PROCEDURES 6
PART II - OTHER INFORMATION 7
ITEM 1. LEGAL PROCEEDINGS. 7
ITEM 1A. RISK FACTORS. 7
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS. 7
ITEM 3. DEFAULTS UPON SENIOR SECURITIES. 7
ITEM 4. MINE SAFETY DISCLOSURES. 7
ITEM 5. OTHER INFORMATION. 7
ITEM 6. EXHIBITS. 8
SIGNATURES 9

2

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

OMNIQ CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

March 31, 2025 December 31, 2024
(In thousands, except share and per share data) As of
March 31, 2025 December 31, 2024
( UNAUDITED )
ASSETS
Current assets
Cash and cash equivalents $ 2,712 $ 2,349
Accounts receivable, net 15,798 20,945
Inventory, net 4,326 7,405
Prepaid expenses 1,089 1,085
Other current assets 103 96
Total current assets 24,028 31,880
Property and equipment, net of accumulated depreciation 684 721
Goodwill 2,862 2,918
Trade name, net of accumulated amortization 1,120 1,187
Customer relationships, net of accumulated amortization 2,909 3,115
Other intangibles, net of accumulated amortization 384 410
Right of use lease asset 884 1,076
Other assets 2,239 2,282
Total Assets $ 35,110 $ 43,589
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable and accrued liabilities $ 64,850 $ 66,097
Line of credit 269 535
Accrued payroll and sales tax 2,774 2,903
Notes payable – current portion 7,857 8,512
Lease liability – current portion 632 701
Other current liabilities 2,808 7,575
Total current liabilities 79,190 86,323
Long-term liabilities
Accrued interest and accrued liabilities, related party 73 73
Notes payable, less current portion 644 234
Lease liability 225 353
Other long term liabilities 469 494
Total liabilities 80,601 87,477
Commitments and Contingencies - -
Stockholders’ equity (deficit)
Series A Preferred stock; $ 0.001 par value; 2,000,000 shares designated, 0 shares issued and outstanding - -
Series B Preferred stock; $ 0.001 par value; 1 share designated, 0 shares issued and outstanding - -
Series C Preferred stock; $ 0.001 par value; 3,000,000 shares designated, 502,000 shares issued and outstanding, respectively 1 1
Common stock; $ 0.001 par value; 35,000,000 shares authorized; 10,712,930 and 10,712,930 shares issued and outstanding, respectively. 11 11
Additional paid-in capital 78,715 78,713
Accumulated (deficit) ( 125,995 ) ( 123,899 )
Accumulated other comprehensive income 1,777 1,286
Total OmniQ stockholders’ equity (deficit) ( 45,491 ) ( 43,888 )
Total liabilities and stockholders’ equity (deficit) $ 35,110 $ 43,589

The accompanying unaudited notes should be read in conjunction with these unaudited condensed consolidated financial statements.

F- 1

OMNIQ CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

(In thousands, except share and per share data) 2025 2024
For the Three months ended
March 31
(In thousands, except share and per share data) 2025 2024
Revenues $ 19,903 $ 18,317
Cost of goods sold 14,762 13,259
Gross profit 5,141 5,058
Operating expenses
Research & Development 507 405
Selling, general and administrative 5,064 5,565
Depreciation 28 116
Amortization 232 231
Total operating expenses 5,831 6,317
Loss from operations ( 690 ) ( 1,259 )
Other income (expenses):
Interest expense ( 462 ) ( 917 )
Other (expenses) income ( 973 ) 31
Total other expenses ( 1,435 ) ( 886 )
Net Loss Before Income Taxes ( 2,125 ) ( 2,145 )
Current Provision for Income Taxes 36 47
Total Provision for Income Taxes 36 47
Net Loss $ ( 2,089 ) $ ( 2,098 )
Net Loss $ ( 2,089 ) $ ( 2,098 )
Foreign currency translation adjustment 491 241
Comprehensive loss $ ( 1,598 ) $ ( 1,857 )
Reconciliation of net loss to net loss attributable to common shareholders
Net loss $ ( 2,089 ) $ ( 2,098 )
Less: Dividends attributable to non-common stockholders’ of OmniQ Corp ( 7 ) ( 7 )
Net loss attributable to common stockholders’ of OmniQ Corp $ ( 2,096 ) $ ( 2,105 )
Net (loss) per share - basic attributable to common stockholders’ of OmniQ Corp $ ( 0.20 ) $ ( 0.20 )
Weighted average number of common shares outstanding - basic 10,712,930 10,688,340

The accompanying unaudited notes should be read in conjunction with these unaudited condensed consolidated financial statements.

F- 2

OMNIQ CORP.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(UNAUDITED)

For the Three Months ended March 31, 2024 and 2025

(In thousands) Shares Amount Shares Amount Capital Deficit Income (Loss) (Deficit)
Series C Additional Accumulated Other Total Stockholders’
Preferred Stock Common Stock Paid-in Accumulated Comprehensive Equity
(In thousands) Shares Amount Shares Amount Capital Deficit Income (Loss) (Deficit)
Balance, December 31, 2023 502 $ 1 10,675 $ 11 $ 78,340 $ ( 113,923 ) $ 551 $ ( 35,020 )
Dividend on Class C Shares - - - - - ( 7 ) - ( 7 )
CodeBlocks Acquisition - - - - - 56 - 56
ESPP Stock Issuance - - 15 - 6 - - 6
Stock-based compensation – options, warrants, issuances - - - - 293 - - 293
Cumulative Translation Adjustment - - - - - - 241 241
Net (loss) income - - - - - ( 2,098 ) - ( 2,098 )
Balance, March 31, 2024 502 $ 1 10,690 $ 11 $ 78,639 $ ( 115,972 ) $ 792 $ ( 36,529 )
Balance, December 31, 2024 502 $ 1 10,712 $ 11 $ 78,713 $ ( 123,899 ) $ 1,286 $ ( 43,888 )
Dividend on Class C Shares - - - - - ( 7 ) - ( 7 )
Stock-based compensation – options, warrants, issuances - - - - 2 - - 2
Cumulative Translation Adjustment - - - - - 491 491
Net (loss) income - - - - - ( 2,089 ) - ( 2,089 )
Balance, March 31, 2025 502 $ 1 10,712 $ 11 $ 78,715 $ ( 125,995 ) $ 1,777 $ ( 45,491 )

The accompanying unaudited notes should be read in conjunction with these condensed unaudited consolidated financial statements.

F- 3

OMNIQ CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

For the Three Months Ended March 31,

(In thousands) 2025 2024
Cash flows from operations
Net loss $ ( 2,089 ) $ ( 2,098 )
Adjustments to reconcile net loss to net cash provided by operating activities:
Stock-based compensation 2 293
Depreciation and amortization 285 347
Amortization of ROU asset 184 299
Loss from sale of other assets ( 4 ) -
Changes in operating assets and liabilities:
Accounts receivable 5,277 ( 508 )
Prepaid expenses ( 8 ) 181
Inventory 3,039 640
Other assets 45 242
Accounts payable and accrued liabilities ( 765 ) 696
Accrued payroll and sales taxes payable ( 127 ) 795
Lease liability ( 189 ) ( 302 )
Deferred tax assets, net ( 45 ) ( 719 )
Other liabilities ( 4,587 ) ( 489 )
Net cash provided by (used in) operating activities 1,018 ( 623 )
Cash flows from investing activities
Purchase of property and equipment ( 31 ) ( 48 )
Net cash (used in) investing activities ( 31 ) ( 48 )
Cash flows from financing activities
Proceeds from ESPP stock issuance - 6
Payments on notes/loans payable ( 903 ) ( 1,133 )
Proceeds from draw on line of credit ( 262 ) 156
Net cash (used in) provided by financing activities ( 1,165 ) ( 971 )
Net change in cash and cash equivalents ( 178 ) ( 1,642 )
Effect of foreign exchange rates on cash and cash equivalents 541 845
Cash and cash equivalents at beginning of period 2,349 1,678
Cash and cash equivalents at end of period $ 2,712 $ 881
Non-cash activities:
Declared dividends payable $ 7 $ 7
Right of use asset acquired in exchange for lease liability $ - $ 1,284
Supplemental disclosure of cash flow information:
Cash paid for interest $ 450 $ 916
Cash paid for income taxes $ - $ -

The accompanying unaudited notes are an integral part of these unaudited condensed consolidated financial statements.

F- 4

OMNIQ CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The condensed consolidated financial statements include the accounts of OMNIQ Corp, and its wholly owned subsidiaries, referred to herein as “we,” “us,” “OMNIQ,” or the “Company.” Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the year ended December 31, 2024 (the “2024 Form 10-K”).

We describe our significant accounting policies in Note 2 of the notes to consolidated financial statements in the 2024 Form 10-K. During the three-month period ended March 31, 2025, there were no significant changes to those accounting policies other than below.

Accounting Standards Updates

ASU 2023-09, “Income Taxes (Topic 740), Improvement to Income Tax Disclosures.” The amendments in ASU 2023-09 require an entity to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold, which is greater than five percent of the amount computed by multiplying pretax income by the entity’s applicable statutory rate, on an annual basis. Additionally, the amendments in this ASU require an entity to disclose the amount of income taxes paid (net of refunds received) disaggregated by federal, state, and foreign taxes and the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions that are equal to or greater than five percent of total income taxes paid (net of refunds received). Lastly, the amendments in this ASU require an entity to disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign and income tax expense (or benefit) from continuing operations disaggregated by federal, state, and foreign. This ASU is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied on a prospective basis; however, retrospective application is permitted. The adoption of ASU 2023-09 is not expected to have a material impact on the Company’s financial statements.

Net Loss Per Common Share

Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share”. Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the three-months ended March 31, 2025, and 2024 were 10,712,930 and 10,688,340 , respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive.

The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported as of:

March 31, 2025 March 31, 2024
Options to purchase common stock 1,342,833 1,372,333
Warrants to purchase common stock 759,235 1,606,734
Potential shares excluded from diluted net loss per share 2,102,068 2,979,067

F- 5

NOTE 2 – GOING CONCERN

The accompanying condensed consolidated financial statements have been prepared assuming that we will continue as a going concern. The following are the principal conditions or events which potentially raise substantial doubt about the company’s ability to continue as a going concern:

Balancing the need for operational cash with the need to add additional products.
Timely and cost-effective development of products
Working capital deficit of $ 55.1 million as of March 31, 2025
Accumulated deficit of $ 126 million as of March 31, 2025
Multiple years of losses from operations

Management Evaluation

Management considers the conditions outlined above as the most significant factors in raising substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financial statements are issued.

Management’s Plans to Mitigate and Alleviate Conditions or Events

Management is evaluating operating expenses and is developing a plan to reduce expenditures without negatively impacting current operations.
Management has placed a strategic focus on increasing sales with prime customers.
Sales efforts are focused on the most profitable product lines.
Blue Star - The Company’s total accounts payable due to Blue Star as of March 31, 2025, was approximately $ 56.6 million. Blue Star is an unsecured creditor, financing a substantial amount the Company’s supply chain demand. Management believes that Blue Star will continue supplying the Company with preferable credit terms. Blue Star has agreed to the annual interest rate of 5 % on invoices that are past due. As an unsecured creditor of the Company, Blue Star has no incentive to force a liquidation. The Company has enjoyed a good mutual relationship for the past six years.

NOTE 3 – CONCENTRATIONS

For the three-months ended March 31, 2025, and the year ended December 31, 2024, no customer accounted for more than 10 % and one customer accounted for 23.7 %, respectively, of the Company’s consolidated revenues.

Accounts receivable at March 31, 2025 and December 31, 2024 are made up of trade receivables due from customers in the ordinary course of business. One customer accounted for 11.2 % of the outstanding receivables as of March 31, 2025, and 26 % as of December 31, 2024.

For the three months ended March 31, 2025, and the year ended December 31, 2024 one vendor made up 45 % and 47 %, respectively, of our purchases.

F- 6

NOTE 4 – BUSINESS COMBINATIONS

CodeBlocks LTD


On January 30, 2024, OMNIQ’s wholly owned subsidiary, Dangot Computers Ltd. (“Dangot”), entered into a Share Purchase Agreement (the “Purchase Agreement”) with CodeBlocks Ltd. (CodeBlocks”) and CodeBlocks’ owners, Alina Lifshits and Erez Attia pursuant to which Dangot, acquired all of the capital stock of CodeBlocks in exchange for NIS 4,666,664 (approximately US $ 1,275,044 ). The consideration is payable in seven equal installments with the final payment due on November 1, 2025. The note has no explicit interest rate so the Company used an implicit interest rate of 8 %; therefore the present value for the acquisition was NIS 4,356,720 , approximately $ 1,190,360 . The purchase Agreement closed on February 1, 2024. As of March 31, 2025, the total amount outstanding is NIS 4.4 million, approximately $ 1 million USD, and is presented on the balance sheet in short- and long-term notes payable.

NOTE 5 – INVENTORY

Inventory consisted of the following as of:

In thousands March 31, 2025 December 31, 2024
Raw materials $ 266 $ 287
Inventory in transit 1,126 4,471
Finished goods (less allowance) 4,019 3,978
Less allowance for obsolescence ( 1,085 ) ( 1,331 )
Total inventories $ 4,326 $ 7,405

NOTE 6 – CREDIT FACILITIES AND LINE OF CREDIT

We maintain operating lines of credit, factoring and revolving credit facilities with banks and finance companies to provide us with working capital.

On January 18, 2024, the Company’s wholly owned subsidiary, Quest Marketing, Inc. (“Quest”) entered into a Purchase and Sale Agreement with Prestige Capital Finance, LLC (“Prestige”), in which Quest has sold, transferred and assigned all of its rights, title, and interest to specific accounts receivable owed to Quest. The maximum outstanding balance of Quest to Prestige shall be $ 7.5 million. The discount fee starts at 1.5 % and increases based on the age of the outstanding receivables. The balance as of March 31, 2025, was $ 0 .

NOTE 7 – RELATED PARTY NOTES PAYABLE

Note Payable – Marin

In December 2017, we entered into a $ 660 thousand note payable at 1.89 % annual interest rate (the “Marin Note”) with two individuals from whom we previously acquired their company (in 2014). The Marin Note was payable in 60 monthly principal payments of $ 20 thousand beginning in October 2018. Accrued interest payable as of March 31, 2025 and December 31, 2024, was $ 73 thousand and $ 73 , respectively. Accrued interest was payable at maturity. This accrued interest was outstanding as of March 31, 2025.

F- 7

NOTE 8 – OTHER NOTES PAYABLE

(In thousands) March 31, 2025 December 31, 2024
Note payable other 8,501 8,746
Less current portion ( 7,857 ) ( 8,512 )
Long-term notes payable $ 644 $ 234

Notes Payable Other

On July 29, 2021, the Company entered into a long-term loan from Leumi Bank totaling NIS 7 million, which at the time was approximately $ 2.16 million. The note accrues interest at the Israeli Prime Rate plus 4.5 % which currently equals 8.25 % per annum and is payable in 8 instalments of principal and interest over 4 years. The note is secured by shares of Dangot Computers, Ltd At December 31, 2024, the balance owed is $ 1,815,840 and at March 31, 2025, the balance owed is $ 1,886,466 NIS (approx. $ 528,211 USD).

On August 11, 2021, the Company purchased vehicles using cash and financing of NIS 500 thousand, approximately $ 155 thousand, to be paid off in monthly interest and principal payments over 5 years. The loan accrues interest at 7.5 % per annum and is secured by the vehicles.

On September 13, 2022, the Company entered into a long-term loan from Hapoalim Bank totaling NIS 3 million, approximately US $ 0.9 million. The note accrues interest at 7.28 % per annum (Israeli Prime Rate plus 1.28 %) and is payable in 36 installments of principal and interest over 3 years. The balance at March 31, 2025 was approximately $ 0.14 million.

During the year ended December 31, 2023, the Company entered into a short-term loan Hapoalim Bank totaling NIS 2.5 million, approximately US $ 0.67 million. The note accrues interest at 7.3 % per annum. The loan is renewed every month at Israeli Prime Rate plus + 1.3 %, which at December 31, 2024 was 7.3 %. In February 2024, NIS 1.5 million of the loan was converted into a short-term loan to be repaid in 12 installments, bearing interest at Prime + 1.5 %. In July 2024, an additional 1.5 million was converted into a long-term loan to be repaid in 18 installments, bearing interest at a rate of Prime + 1.5 %. At December 31, 2024, the Company owed Hapoalim Bank USD $ 1.39 million. At March 31, 2025, the balance was approximately $ 1.5 million.

F- 8

During the year ended December 31, 2023, the Company entered into a short-term loan from Bank Leumi totaling NIS 21.5 million, approximately US $ 5.9 million. The note accrues interest at 7.6 % per annum. The loan is renewed every month at Israeli Prime Rate plus 1.89 , which at December 31, 2024 was 7.89 %. In March 2024, NIS 7.5 million of the loan was converted into a long-term loan to be repaid in 36 installments, bearing interest at a rate of Prime + 3.25 %, which at December 31, 2024 was 9.25 %. At December 31, 2024, the Company owed Bank Leumi USD $ 5.4 million. At March 31, 2025, the Company owed Bank Leumi approximately USD $ 5.4 million.

On September 21, 2023, the Company entered into a long-term loan from Tzameret Mimunim totaling 1.5 M NIS, approximately US $ 393 thousand. The note accrues interest at the Israeli Prime Rate plus 3.5 % which currently equals 9.5 % per annum and is payable in 36 monthly installments. The balance at December 31, 2024 is $ 251 thousand and at March 31, 2025 was $ 212 thousand.

As of March 31, 2025, the Company was not in compliance with certain financial covenants related to the Bank Leumi and Bank Hapoalim debt. The Company’s failure to comply with these financial covenants could result in an event of default under its debt agreements. Therefore, we reclassified the total balance as current debt on the balance sheet. The Company is actively pursuing options to address its noncompliance. The lenders have not requested early repayment of the loan as of the date when these financial statements were available to be issued.

NOTE 9 – OTHER INCOME

For the three months ended March 31, 2025, the Company received government relief funds in the amount of approximately NIS 1.7 million or US $ 609 thousand.

NOTE 10 – STOCKHOLDERS’ EQUITY

PREFERRED STOCK

Series A

As of March 31, 2025, there were 2,000,000 Series A preferred shares designated and no Series A preferred shares outstanding. The board of directors of the Company (the “Board”) had previously set the voting rights for the Series A preferred stock at 1 share of preferred to 13 common shares .

Series B

As of March 31, 2025, there was 1 preferred share designated and no preferred shares outstanding.

Series C

As of March 31, 2025, there were 3,000,000 Series C Preferred Shares (“Series C”) authorized with 502,000 issued and outstanding. The Series C shares have preferential rights above common shares and the Series B Preferred Shares and is entitled to receive a quarterly dividend at a rate of $ 0.06 per share per annum and have a liquidation preference of $ 1 per share. Series C shares outstanding are convertible into common stock at the rate of 20 preferred shares to one share of common stock . As of March 31, 2025, the accrued dividends on the Series C Preferred Stock was $ 219 thousand.

The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) and automatically converts into Common Stock at $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) in the event that the Company’s common stock has a closing price of $30 per share for 20 consecutive trading days .

F- 9

EQUITY INCENTIVE PLAN

In October 2021, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, advisors, and employees to the Company. Pursuant to the Plan, 1,118,856 shares of the Company’s common stock, par value $ 0.001 (the “Shares”), were set aside and reserved for issuance. The Plan was approved by our stockholders at the December 2021, shareholders’ meeting. No shares were issued in the three months ended March 31, 2025 and 14,409 shares were issued during the three months ended March 31, 2024.

NOTE 11 – LITIGATION

The Company was named a defendant in a case involving a former employee who claims he is owed approximately $ 60 thousand in unpaid commissions. This case was settled in February 2024.

On November 3, 2024 a commercial real estate company filed a lawsuit against Dangot Computers, OmniQ Technologies and some of Dangot’s officers alleging breach of a letter of intent for a lease arrangement. The claims were brought in an Israeli court. The initial claim against Dangot Computers is NIS 21 million approximately US $ 5.6 million. The Company believes that it has meritorious defenses to such action and intends to vigorously defend itself; however, at this stage it is too early to assess the chances of the lawsuit with certainty.

In March 2025, the Company was named a defendant in a case involving a consultant who was terminated and who claims he is owed approximately $ 389 thousand in unpaid fees and commissions. The Company believes it has multiple defenses and cross claims against the former consultant and is evaluating its response to the lawsuit, but plans to vigorously defend the suit.

NOTE 12 – BUSINESS SEGMENT

The Company operates in a single reportable segment, referred to as providing solutions including hardware, software, communications, and automated management service as an established distributor of barcode labels, tags, and ribbons, as well as RFID labels and tags. The business is managed by the chief executive officer who is the Chief Operating Decision Maker (CODM). The CODM evaluates segment performance based on operating income (loss) for purposes of allocating resources and evaluating financial performance.  The accounting policies of our single reportable segment are the same as those for the Company as a whole.

NOTE 13 – SUBSEQUENT EVENTS

None

F- 10

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

PRELIMINARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements include statements preceded by, followed by, or that include the words “may”, “could”, “would”, “should”, “believe”, “expect”, “anticipate”, “plan”, “estimate”, “target”, “project”, “intend”, “foresee” and similar expressions. These statements include, among others, statements regarding our expected business outlook, anticipated financial and operating results, our business strategy and means to implement the strategy, our objectives, the amount and timing of capital expenditures, the likelihood of our success in expanding our business, financing plans, budgets, working capital needs, and sources of liquidity. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.

Forward-looking statements are only predictions and are not guarantees of performance. These statements are based on our management’s beliefs and assumptions, which in turn are based on currently available information. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the expansion of product offerings geographically or through new marketing applications, the timing and cost of planned capital expenditures, competitive conditions, and general economic conditions. These assumptions could prove inaccurate. Forward-looking statements also involve known and unknown risks and uncertainties, which could cause actual results to differ materially from those contained in any forward-looking statement. In addition, even if our actual results are consistent with the forward-looking statements contained in this Quarterly Report on Form 10-Q, those results may not be indicative of results or developments in subsequent periods. Many of these factors are beyond our ability to control or predict. Such factors include, but are not limited to, the following:

Our ability to raise capital when needed and on acceptable terms and conditions;
Our ability to manage credit and debt structures from vendors, debt holders, and secured lenders.
Our ability to manage the growth of our business through internal growth and acquisitions;
Competitive pressures;
Our ability to attract and retain management, and to integrate and maintain technical information and management information systems.
Compliance with laws and regulations, including those relating to environmental matters, corporate governance matters and tax matters, as well as any future changes to such laws and regulations; and

For a more detailed discussion of some of the foregoing risks and uncertainties, see Item 1A — “Risk Factors” in our 2024 Form 10-K and Item 1A — “Risk Factors” in this Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, as well as other reports and registration statements filed by us with the SEC. These factors should not be construed as exhaustive and should be read with other cautionary statements in this Quarterly Report on Form 10-Q and our other public filings. For more information about us and the announcements we make from time to time, visit our website at www.omniq.com.

Introduction

We use patented and proprietary artificial intelligence (AI) technology to deliver data collection, real-time surveillance and monitoring for supply chain management, homeland security, public safety, traffic & parking management, and access control applications. The technology and services we provide help our clients move people, assets, and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.

Our principal solutions include hardware, software, communications, and automated management services. We are an established distributor of barcode labels, tags, and ribbons, as well as RFID labels and tags. We provide printing solutions, credit card terminals, automatic kiosks and point-of-care units. We also offer technical service and support. Our highly tenured team of professionals has the knowledge and expertise to simplify the integration process for our customers, and our team delivers proven problem-solving solutions backed by numerous customer references. We offer comprehensive packaged and configurable software, and we are a leading provider of best-in-class mobile and wireless equipment.

Our customers include government agencies and leading Fortune 500 companies from diverse sectors, including healthcare, food and beverage, manufacturing, retail, distribution, and transportation and logistics. Since 2014, our annual consolidated revenues have grown to more than $80 million with clients in more than 40 countries. We currently engage with several billion-dollar markets with double-digit growth, including the Global Safe City market and the Ticketless Safe Parking market.

3

The following is a discussion of our financial condition, results of operations, financial resources, and working capital. This discussion and analysis should be read in conjunction with our unaudited condensed consolidated financial statements contained in this Form 10-Q.

OVERVIEW

The Company’s sales from operations for the three months ended March 31, 2025, were $19.9 million, an increase of approximately $1.6 million or 8.7%, over the three months ended March 31, 2024.

The loss from operations for the three months ended March 31, 2025, was $690 thousand, a decrease of $569 thousand compared with the loss in the three months ended March 31, 2024, of $1.3 million. Basic loss per share from continuing operations for the three months ended March 31, 2025, was ($0.20) versus ($0.20) per share for the same period in 2024. Comprehensive loss for the three months ended March 31, 2025 and 2024 was $1.6 million and $1.9 million respectively, the only component to comprehensive loss besides net loss is foreign currency translation.

LIQUIDITY AND CAPITAL RESOURCES

As of March 31, 2025, the Company had cash in the amount of $2.7 million and a working capital deficit of $55 million, compared to cash in the amount of $2.3 million, and a working capital deficit of $54.4 million as of December 31, 2024. The Company had stockholders’ deficit attributable to OmniQ stockholders of $45.5 million and $43.8 million as of March 31, 2025, and December 31, 2024, respectively. This increase in our stockholders’ deficit was primarily attributable to net losses.

The Company’s accumulated deficit was $126 million and $124 million as of March 31, 2025, and December 31, 2024.

The Company’s operations provided net cash of $1 million and used $623 thousand in the three months ended March 31, 2025, and 2024, respectively. The increase in cash provided in operations of $1.6 million is due to the increase in revenue.

The Company’s cash used in investing activities was $31 thousand for the three months ended March 31, 2025, compared to cash used in investing activities of $48 thousand for the three months ended March 31, 2024.

The Company’s financing activities used $1.2 million of cash during the three months ended March 31, 2025, and used $971 thousand during the three months ended March 31, 2024.

4

Results of Operations

The following tables set forth certain selected unaudited condensed consolidated statements of operations data for the periods indicated in dollars. In addition, we note that the period-to-period comparison may not be indicative of future performance.

For the 3 months ended
March 31,
Variation
In thousands 2025 2024 $ %
Revenue $ 19,903 $ 18,317 $ 1,586 8.66 %
Cost of Goods sold 14,762 13,259 1,503 11.34 %
Gross Profit 5,141 5,058 83 1.64 %
Operating Expenses 5,831 6,317 (486 ) (7.69 )%
Loss from operations (690 ) (1,259 ) 569 (45.19 )%
Net loss (2,089 ) (2,098 ) 9 (0.43 )%
Net Loss per common Share from continuing operations $ (0.20 ) $ (0.20 ) $ 0.00 (0.00 )%

Revenues

For the three months ended March 31, 2025, and 2024, the Company generated net revenues in the amount of $19.9 million and $18.3 million, respectively. The increase between the three-month periods was attributable to acceleration of projects by customers.

Cost of Goods Sold

For the three months ended March 31, 2025, and 2024, the Company recognized a total of $14.8 million and $13.3 million, respectively, of cost of goods sold. For the three months ended March 31, 2025, and 2024, cost of goods sold were 74% and 72% of net revenues, respectively.

Operating expenses

Total operating expenses for the three months ended March 31, 2025, and 2024 recognized was $5.8 million and $6.3 million, respectively, representing a 7.7% decrease. The decrease in operating expenses was due primarily to management’s cost savings plan.

Research and Development – Research and development expenses for the three months ended March 31, 2025, and 2024 totaled $507 thousand and $405 thousand, respectively.

Selling, general and Administrative – Selling, general and administrative expenses for the three months ended March 31, 2025, and 2024 totaled $5.1 million and $5.6 million, respectively, representing a 9% decrease. The decrease was due primarily to management’s cost savings plan.

Depreciation – Depreciation expenses for the three months ended March 31, 2025, and 2024 totaled $28 thousand and $116 thousand, respectively, representing a 76% decrease. The decrease is directly related to the reduction in fixed assets.

Intangible amortization – Intangible amortization expenses for the three months ended March 31, 2025, and 2024 totaled $232 thousand and $231 thousand, respectively. The increase is due to life of intangibles and what is remaining to be amortized.

Other income and expenses

Interest Expense – Interest expense for the three months ended March 31, 2025, totaled $462 thousand, as compared to $917 thousand for the three months ended March 31, 2024. The decrease is primarily attributable to the reduced line of credit.

Inflation

The Company’s results of operations have not been materially affected by inflation and management does not expect inflation to have a material impact on its operations in the future.

Off- Balance Sheet Arrangements

The Company currently does not have any off-balance sheet arrangements.

5

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not Applicable

ITEM 4. CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure and Control Procedures

We maintain “disclosure controls and procedures”, as such terms are defined under Exchange Act Rule 13a-15(e), that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Principal Accounting Officer, as appropriate, to allow timely decisions regarding required disclosures. The Company acknowledges that any controls and procedures can provide only reasonable assurances of achieving the desired control objectives.

We have carried out an evaluation as required by Rule 13a-15(d) under the supervision of and with the participation of our management, including our Chief Executive Officer and Principal Accounting Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2025. Based upon their evaluation, the Chief Executive Officer and Principal Accounting Officer concluded that, as of March 31, 2025, the Company’s disclosure controls and procedures were not effective. Although we have determined that the existing controls and procedures are not effective, the deficiencies identified have not been deemed material to our reporting disclosures.

(b) Management’s Report on Internal Controls over Financial Reporting

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Internal control over financial reporting refers to the process designed by, or under the supervision of, our Chief Executive Officer and Principal Accounting Officer, and affected by our Board, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Internal control over financial reporting cannot provide absolute assurance of achieving their objectives. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgement and breakdowns resulting from human failures. Due to their inherent limitations, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. It is possible to design safeguards to reduce, but not eliminate, this risk. Management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company.

Management has used the framework set forth in the report entitled Internal Control—Integrated Framework published by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), known as COSO, to evaluate the effectiveness of our internal control over financial reporting.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Based on such an evaluation, our CEO concluded that, as of March 31, 2025, our internal controls over financial reporting were not effective.

As a result of our evaluation, we identified a material weakness in our controls related to segregation of duties and other immaterial weaknesses in several areas of data management and documentation.

Our management is composed of a small number of professionals resulting in a situation where limitations on segregation of duties exist. Accordingly, and as a result of the material weakness identified above, we have concluded that the control deficiencies result in a reasonable possibility that a material misstatement of the annual or interim financial statements may not be prevented on a timely basis by the Company’s internal controls. We continue to employ and refine a structure in which critical accounting policies, issues and estimates are identified, and together with other complex areas, are subject to multiple reviews by executives. In addition, we evaluate and assess our internal controls and procedures regarding our financial reporting, utilizing standards incorporating applicable portions of the Public Company Accounting Oversight Board’s 2009 Guidance for Smaller Public Companies in Auditing Internal Controls Over Financial Reporting as necessary on an on-going basis.

While the material weakness set forth above was the result of the scale of the Company’s operations and is intrinsic to its small size, the Company believes the risk of material misstatements relative to financial reporting are minimal.

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by its registered public accounting firm pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, which permits the Company to provide only management’s report in this annual report.

(c) Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

6

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company was named a defendant in a case involving a former employee who claims he is owed approximately $60 thousand in unpaid commissions. This case was settled in February 2024.

On November 3, 2024 a commercial real estate company filed a lawsuit against Dangot Computers, OmniQ Technologies and some of Dangot’s officers alleging breach of a letter of intent for a lease arrangement. The claims were brought in an Israeli court. The initial claim against Dangot Computers is NIS 21 million approximately US $5.6 million. The Company believes that it has meritorious defenses to such action and intends to vigorously defend itself. At this early stage, it is not possible to fully assess the chances of a lawsuit.

In March 2025, the Company was named a defendant in a case involving a consultant who was terminated and who claims he is owed approximately $389 thousand in unpaid fees and commissions. The Company believes it has multiple defense and cross claims against the former consultant and is evaluating its response to the lawsuit, but plans to vigorously defend the suit.

ITEM 1A. RISK FACTORS

Not applicable.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

WHERE YOU CAN FIND ADDITIONAL INFORMATION

We have filed with the Securities and Exchange Commission this Form 10-Q, including exhibits. You may read and copy all or any portion of the registration statement or any reports, statements, or other information in the files at SEC’s Public Reference Room located at 100 F Street, NE., Washington, DC 20549, on official business days during the hours of 10 a.m. to 3 p.m.

You can request copies of these documents upon payment of a duplicating fee by writing to the Commission. You may call the Commission at 1-800-SEC-0330 for further information on the operation of its public reference room. Our filings, including the registration statement, will also be available to you on the website maintained by the Commission at http://www.sec.gov.

We intend to furnish our stockholders with annual reports which will be filed electronically with the SEC containing the consolidated financial statements audited by our independent auditors, and to make available to our stockholder’s quarterly reports for the first three quarters of each year containing unaudited interim consolidated financial statements.

Our website is located at http://www.omniq.com. The Company’s website and the information contained on that site, or connected to that site, is not part of or incorporated by reference into this filing.

7

ITEM 6. EXHIBITS

EXHIBIT INDEX

10.1 Share purchase Agreement dated May 3, 2021, by and between OMNIQ Corp, OMNIQ Technologies Ltd. and Haim Dangot. (incorporated by reference to the Current Report on Form 8-k filed with the SEC on May 6, 2021)
31.1 Certification of our Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 Certification of our Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 Certification of our Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

101.INS Inline XBRL Instance Document.
101.SCH Inline XBRL Taxonomy Extension Schema Document.
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

8

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 15, 2025

OMNIQ CORP.
By: /s/ Shai Lustgarten
Shai Lustgarten
Chief Executive Officer, Interim Chief Financial Officerand Chairman of the Board

9

TABLE OF CONTENTS